Home
Home

Aastrom Biosciences

Investing In The Stem Cell Sector: An Overview

Investing In The Stem Cell Sector: An Overview
Seeking Alpha

Companies That Can Mend The Biotech Market: Stephen Brozak

Companies That Can Mend The Biotech Market: Stephen Brozak
Seeking Alpha

Aastrom's Shocking News And Future Potential

Aastrom's Shocking News And Future Potential
Seeking Alpha

Aastrom Biosciences cutting workforce by about 50 percent, ending clinical drug trial

Aastrom Biosciences cutting workforce by about 50 percent, ending clinical drug trial
Yahoo/AP

Aastrom Biosciences Finds a CEO

Aastrom Biosciences Finds a CEO
Motley Fool

Is Takeda Interested In Aastrom Bio?

Is Takeda Interested In Aastrom Bio?
Seeking Alpha

The Stem Cell Sector Further Validates Itself With A Successful Q3

The Stem Cell Sector Further Validates Itself With A Successful Q3
Seeking Alpha

Aastrom Biosciences' CEO Discusses Q3 2012 Results - Earnings Call Transcript

Aastrom Biosciences' CEO Discusses Q3 2012 Results - Earnings Call Transcript
Seeking Alpha

Stem Cell Therapy Outlook Starting To Match Clinical Results

Stem Cell Therapy Outlook Starting To Match Clinical Results
Seeking Alpha

Stem Cell Therapy Gaining Ground And Investor Attention

Stem Cell Therapy Gaining Ground And Investor Attention
Seeking Alpha